Novavax (NVV1.F) Stock Price

€7.31 4.2%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    1

  • Fundamental

    2

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Novavax, AI stock picks, stock alerts and much more.

Sign up

NVV1.F AI Stock Analysis

AI stock analysis for NVV1.F is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novavax (NVV1.F) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Novavax (NVV1.F) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novavax (NVV1.F), currently trading at €7.31, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About NVV1.F

LSE

Similar Stocks

5CV.F CureVac
5CV.F		 €2.77
0.4%
4
22UA.F BioNTech SE
22UA.F		 €90.35
3.1%
5
HPHA.DE Heidelberg Pharma AG
HPHA.DE		 €2.59
0.4%
5
MDG1.DE Medigene AG
MDG1.DE		 €1.57
6.7%
2
FYB.DE Formycon AG
FYB.DE		 €26.65
2.7%
6

News

The CDC Reveals ACIP Members’ Conflicts of Interest. It’s Just the Tip of the Iceberg.

The CDC Reveals ACIP Members’ Conflicts of Interest. It’s Just the Tip of the Iceberg.
March 14, 2025. Lewrockwell.com
TScan Therapeutics (NASDAQ:TCRX) & Novavax (NASDAQ:NVAX) Financial Comparison

TScan Therapeutics (NASDAQ:TCRX) & Novavax (NASDAQ:NVAX) Financial Comparison
March 13, 2025. ETF Daily News
White House withdraws vaccine critic Weldon for CDC director

White House withdraws vaccine critic Weldon for CDC director
March 13, 2025. CNA
Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Analysts

Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Analysts
March 11, 2025. ETF Daily News

NVV1.F Alternative Data

Web Traffic

Novavax receives an estimated 33215 monthly visitors to novavax.com.

  • Web Traffic

    33215

  • Change from Previous Month

    26.7%

  • 3 Month Change

    24.9%

  • YoY Change

    24.9%

News Mentions

Novavax was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

Twitter Followers

Novavax has 60,896 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    60896

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    1%

TikTok Followers

Novavax has 2,786 TikTok Followers on its main TikTok account, down by -0.3% over the last month.

  • TikTok Followers

    2786

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    37.2%

Facebook Engagement

Novavax has engaged 11 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    11

  • Daily Change

    15.4%

  • 1 Month Change

    45%

  • 3 Month Change

    99.3%

Instagram Followers

Novavax has 3,069 Instagram Followers on its main Instagram account, down by -0.4% over the last month.

  • Instagram Followers

    3069

  • Daily Change

    0.1%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.8%

Youtube Subscribers

Novavax has 1,130 subscribers on its main Youtube channel.

  • Youtube Subscribers

    1130

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.9%

LinkedIn Followers

72,532 are following Novavax on LinkedIn, up by 0.4% over the last month.

  • LinkedIn Followers

    72532

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.5%

Job Postings

Novavax has an estimated 2 open job postings, which is down -77.8% over the last month.

  • Job Postings

    2

  • Daily Change

    33.3%

  • 1 Month Change

    77.8%

  • 3 Month Change

    60%

Reddit Mentions

Novavax has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

LinkedIn Employees

According to LinkedIn, Novavax has 1,179 employees, down by -0.3% over the last month.

  • LinkedIn Employees

    1179

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    15.8%

Business Outlook

According to employee reviews, the business outlook among employees at Novavax is 19 out of 100 (very bearish).

  • Business Outlook

    19

  • Change from Previous Month

    9.5%

  • 3 Month Change

    0%

  • YoY Change

    0%

NVV1.F Financials

NVV1.F Key Metrics

  • Total Revenue

    $84.5M

  • Net Income

    -$121.3M

  • Earnings per Share

    -$0.82

  • Free cash flow

    -$146.8M

  • EBITDA

    -$105.4M

  • EBITDA Ratio

    -1.24711

  • Total Assets

    $1.7B

NVV1.F 2-year Revenue & Income
NVV1.F 2-year Free Cash Flow

NVV1.F Technicals

NVV1.F SMA
NVV1.F RSI

FAQ

What's the current price of Novavax (NVV1.F) Stock?
The price of an Novavax (NVV1.F) share is €7.31.

What's the market cap of Novavax?
The current market cap of Novavax is 1.2B.

Should I buy or sell NVV1.F?
Novavax exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Novavax a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Novavax stock. There are several bearish signals and market challenges that could negatively impact Novavax's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Novavax (NVV1.F) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Novavax stock right now, as the outlook appears bearish.

What are some stocks similar to Novavax (NVV1.F) that investors often compare it to?
Novavax (NVV1.F) is often compared to similar stocks such as CureVac, BioNTech SE, Heidelberg Pharma AG, Medigene AG and Formycon AG.

What is the forecast for Novavax's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novavax's stock price to be around €6.32 in 2026. Starting from the current price of €7.31, this represents a 13.5% change in price, indicating a bearish outlook for the stock.

How to buy Novavax (NVV1.F) Stock?
Novavax stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novavax shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.